CD33 and precursor B-cell acute lymphoblastic leukemia: It is also noteworthy that only markers of myeloid origin were expressed as aberrant phenotype in T-cell ALL (CD13, CD33 and HLA-DR) while common T-cell markers i.e. CD3 and CD7 were aberrantly expressed in 3% cases of B-cell ALL/ TAg+ B-ALL.